CureVac's market cap is currently ―. The company's EPS TTM is $-1.529; its P/E ratio is -1.60; CureVac is scheduled to report earnings on April 24, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	€ 11.21M	€ 20.15M	€ 24.37M	€ 41.23M
Gross Profit	-	€ -12.87M	€ -22.54M	€ -12.86M	€ -28.79M
EBIT	-	€ -47.10M	€ -56.98M	€ -13.25M	€ -4.24M
EBITDA	-	€ -40.41M	€ -49.40M	€ -4.17M	€ 96.00K
Net Income Common Stockholders	-	€ -47.57M	€ -57.58M	€ -15.09M	€ -1.94M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 495.80M	€ 543.46M	€ 577.17M	€ 662.87M	€ 816.11M
Total Assets	€ 860.47M	€ 910.51M	€ 925.82M	€ 1.03B	€ 1.16B
Total Debt	€ 42.09M	€ 41.26M	€ 40.21M	€ 40.66M	€ 28.89M
Net Debt	€ -453.71M	€ -502.20M	€ -536.97M	€ -622.21M	€ -787.22M
Total Liabilities	€ 327.22M	€ 285.52M	€ 302.62M	€ 351.80M	€ 469.77M
Stockholders Equity	€ 509.85M	€ 624.99M	€ 623.20M	€ 674.86M	€ 688.48M
Cash Flow	-
Free Cash Flow	-	€ -63.76M	€ -92.19M	€ -153.70M	€ -217.67M
Operating Cash Flow	-	€ -35.92M	€ -64.66M	€ -136.51M	€ -183.07M
Investing Cash Flow	-	€ -27.84M	€ -27.53M	€ -17.18M	€ -34.60M
Financing Cash Flow	-	€ 26.46M	€ 3.87M	€ -460.00K	€ -33.52M

Currency in EUR

CureVac Earnings and Revenue History

Income Statement >

CureVac Debt to Assets

Balance Sheet >

CureVac Cash Flow

Cash Flow >

CureVac Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing